Literature DB >> 4194359

Comparison of bethanidine, alpha-methyldopa, and reserpine in essential hypertension.

W E Gibb, J S Malpas, P Turner, R J White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4194359     DOI： 10.1016/s0140-6736(70)91327-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

2.  Reserpine as monotherapy for mild hypertension?

Authors:  L Z Feigenbaum
Journal:  West J Med       Date:  1991-06

3.  Carbon monoxide poisoning.

Authors: 
Journal:  West J Med       Date:  1991-06

4.  Drug choice for treatment of hypertension at 'step 2'.

Authors:  L Z Feigenbaum
Journal:  West J Med       Date:  1979-04

5.  Methyldopa hepatitis. Report of three cases.

Authors:  A M Hoyumpa; A M Connell
Journal:  Am J Dig Dis       Date:  1973-03

Review 6.  Fixed combination drug therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

Review 7.  Effects of antihypertensive drugs on endocrine function.

Authors:  E P Brass
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

8.  Reserpine, hydrochlorothiazide and pituitary-gonadal hormones in hypertensive patients.

Authors:  T W Boyden; C A Nugent; T Ogihara; T Maeda
Journal:  Eur J Clin Pharmacol       Date:  1980-05       Impact factor: 2.953
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.